These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1940094)

  • 1. Imipramine in the treatment of depressed Alzheimer's patients: impact on cognition.
    Teri L; Reifler BV; Veith RC; Barnes R; White E; McLean P; Raskind M
    J Gerontol; 1991 Nov; 46(6):P372-7. PubMed ID: 1940094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind trial of imipramine in Alzheimer's disease patients with and without depression.
    Reifler BV; Teri L; Raskind M; Veith R; Barnes R; White E; McLean P
    Am J Psychiatry; 1989 Jan; 146(1):45-9. PubMed ID: 2643356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of imipramine and clinical response among depressed outpatients.
    Matuzas W; Javaid JI; Glass R; Davis JM; Ross JA; Uhlenhuth EH
    J Clin Psychopharmacol; 1982 Apr; 2(2):140-2. PubMed ID: 7042772
    [No Abstract]   [Full Text] [Related]  

  • 4. A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Merideth CH; Feighner JP; Hendrickson G
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):73-7. PubMed ID: 6370981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive dysfunction and imipramine in outpatient depressive.
    Glass RM; Uhlenhuth EH; Hartel FW; Matuzas W; Fischman MW
    Arch Gen Psychiatry; 1981 Sep; 38(9):1048-51. PubMed ID: 7025784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of alprazolam, imipramine, and placebo administered once a day in treating depressed patients.
    Mendels J; Schless AP
    J Clin Psychiatry; 1986 Jul; 47(7):357-61. PubMed ID: 2873131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacology of bupropion and imipramine in elderly depressives.
    Branconnier RJ; Cole JO; Ghazvinian S; Spera KF; Oxenkrug GF; Bass JL
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):130-3. PubMed ID: 6406441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipramine in prepubertal major depressive disorders.
    Puig-Antich J; Perel JM; Lupatkin W; Chambers WJ; Tabrizi MA; King J; Goetz R; Davies M; Stiller RL
    Arch Gen Psychiatry; 1987 Jan; 44(1):81-9. PubMed ID: 3541830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness.
    Rabkin JG; Rabkin R; Harrison W; Wagner G
    Am J Psychiatry; 1994 Apr; 151(4):516-23. PubMed ID: 7908501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
    Fabre LF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paroxetine in major depression: a double-blind trial with imipramine and placebo.
    Cohn JB; Wilcox CS
    J Clin Psychiatry; 1992 Feb; 53 Suppl():52-6. PubMed ID: 1531826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double blind comparison of lofepramine, imipramine and placebo in patients with depression.
    Feighner JP; Meridith CH; Dutt JE; Hendrickson GG
    Acta Psychiatr Scand; 1982 Aug; 66(2):100-8. PubMed ID: 6753500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression.
    Rickels K; Chung HR; Csanalosi IB; Hurowitz AM; London J; Wiseman K; Kaplan M; Amsterdam JD
    Arch Gen Psychiatry; 1987 Oct; 44(10):862-6. PubMed ID: 3310952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipramine is effective after unsuccessful cognitive therapy: sequential use of cognitive therapy and imipramine in depressed outpatients.
    Stewart JW; Mercier MA; Agosti V; Guardino M; Quitkin FM
    J Clin Psychopharmacol; 1993 Apr; 13(2):114-9. PubMed ID: 8463443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind comparison of paroxetine, imipramine, and placebo in major depression.
    Shrivastava RK; Shrivastava SH; Overweg N; Blumhardt CL
    J Clin Psychiatry; 1992 Feb; 53 Suppl():48-51. PubMed ID: 1531825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disappearance of memory deficits in outpatient depressives responding to imipramine.
    Peselow ED; Corwin J; Fieve RR; Rotrosen J; Cooper TB
    J Affect Disord; 1991 Mar; 21(3):173-83. PubMed ID: 1829740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imipramine and chlordiazepoxide in depressive and anxiety disorders. I. Efficacy in depressed outpatients.
    Lipman RS; Covi L; Rickels K; McNair DM; Downing R; Kahn RJ; Lasseter VK; Faden V
    Arch Gen Psychiatry; 1986 Jan; 43(1):68-77. PubMed ID: 3510601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double blind study in out-patients with primary non-agitated depression treated with imipramine in combination with placebo, diazepam or dixyrazine.
    Feet PO; Larsen S; Robak OH
    Acta Psychiatr Scand; 1985 Oct; 72(4):334-40. PubMed ID: 3907277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
    Deltito JA; Argyle N; Klerman GL
    J Clin Psychiatry; 1991 Mar; 52(3):121-7. PubMed ID: 2005075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ECG findings in geriatric depressives given trazodone, placebo, or imipramine.
    Hayes RL; Gerner RH; Fairbanks L; Moran M; Waltuch L
    J Clin Psychiatry; 1983 May; 44(5):180-3. PubMed ID: 6343360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.